Accretive Health, Inc. (OTC Pink: ACHI) today announced that, in
connection with the appointment of David Mason as the company’s chief
strategy officer, on November 11, 2014, Accretive Health granted to
Mason a nonstatutory stock option and shares of restricted common stock
(collectively the “Inducement Grants”) as an inducement material to
Mason’s acceptance of employment with the company.
IMS Health Holdings , Inc. (“IMS Health”) (NYSE:IMS), a leading
global provider of information and technology services to the healthcare
and life sciences industries, today announced results for the quarter
ended September 30, 2014.
- Non-GAAP(1) operating earnings increased 6 percent to $566 million - Non-GAAP diluted earnings per share (EPS) from continuing operations decreased 9 percent to $1.00
- Prior year first quarter included an $0.18 benefit related to tax settlements; excluding this impact, non-GAAP diluted EPS increased 9 percent DUBLIN, Ohio , Oct.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.